📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Risk of gonadotoxicity with immunotherapy and targeted agents remains an unsolved but crucial issue. (2022)

First Author: Lambertini M

Attributed to: Reproductive function in teenage and young adult cancer patients in the UK funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/eci.13779

PubMed Identifier: 35342940

Publication URI: http://europepmc.org/abstract/MED/35342940

Type: Journal Article/Review

Volume: 52

Parent Publication: European journal of clinical investigation

Issue: 7

ISSN: 0014-2972